Biophan to Participate in Nano/Bio Convergence 2004 Conference - News Item

Biophan Technologies, Inc. an innovator, developer and marketer of MRI-related and other advanced biomedical technology, announced today that it will present at the Nano/Bio Convergence 2004 Conference. The conference will focus on the inevitable convergence of nanotechnology and biotechnology, and will take place March 28-30, 2004 at the Hyatt Regency in Cambridge, MA.

The Conference covers applications of nanobiotechnology: molecular diagnostics, molecular imaging, drug discovery, development, and delivery.

NanoView, Biophan's new, recently announced technology, will utilize nanomagnetic particles as contrast agents that preferentially bind to tissues of diagnostic interest, creating improved detail and contrast in images. NanoView is intended to improve signal intensity and permit the use of multiple markers.

This product expansion is part of Biophan's strategy to improve the utility of MRI diagnostics by making all biomedical devices safe and image compatible for use with MRI. Biophan's biomagnetic particle technology has been shown to have unique signature capabilities that can be used in MRI contrast agents.

Posted 23rd March 2004

Tell Us What You Think

Do you have a review, update or anything you would like to add to this article?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.